{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:48:39Z","timestamp":1792190919865,"version":"4.4.0"},"reference-count":128,"publisher":"FapUNIFESP (SciELO)","issue":"3a","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting the motor nervous system. It causes progressive and cumulative physical disabilities in patients, and leads to eventual death due to respiratory muscle failure. The disease is diverse in its presentation, course, and progression. We do not yet fully understand the cause or causes of the disease, nor the mechanisms for its progression; thus, we lack effective means for treating this disease. Currently, we rely on a multidisciplinary approach to symptomatically manage and care for patients who have ALS. Although amyotrophic lateral sclerosis and its variants are readily recognized by neurologists, about 10% of patients are misdiagnosed, and delays in diagnosis are common. Prompt diagnosis, sensitive communication of the diagnosis, the involvement of the patient and their family, and a positive care plan are prerequisites for good clinical management. A multidisciplinary, palliative approach can prolong survival and maintain quality of life. Treatment with Riluzole improves survival but has a marginal effect on the rate of functional deterioration, whereas non-invasive ventilation prolongs survival and improves or maintains quality of life. In this Review, we discuss the diagnosis, management, and how to cope with impaired function and end of life on the basis of our experience, the opinions of experts, existing guidelines, and clinical trials. Multiple problems require a multidisciplinary approach including aggressive symptomatic management, rehabilitation to maintain motor function, nutritional support (enteric feeding, gastrostomy), respiratory support (non invasive home ventilation, invasive ventilation, tracheotomy), augmentative communication devices, palliative care, psychological support for both patients and families (because family members so often play a central role in management and care), communication between the care team, the patient and his or her family, and recognition of the clinical and social effects of cognitive impairment. Social, bioethical, and financial issues as well as advance directives should be addressed. A plethora of evidence-based guidelines should be compiled into an internationally agreed guideline of best practice. The multidisciplinary team has changed the history of disease, with still no curative therapy available.<\/jats:p>","DOI":"10.1590\/s0004-282x2009000400040","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T04:56:12Z","timestamp":1251348972000},"page":"750-782","source":"Crossref","is-referenced-by-count":55,"title":["Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever"],"prefix":"10.1590","volume":"67","author":[{"given":"Acary Souza Bulle","family":"Oliveira","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Dias Batista","family":"Pereira","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"105","article-title":"Motor neuron disease: classification and nomenclature","volume":"1","author":"Swash M","year":"2000","journal-title":"ALS"},{"key":"ref2","series-title":"Amyotrophic lateral sclerosis: diagnostic and management for the clinician","first-page":"219","volume-title":"The legacy of Lou Gehrig's disease: notable people with ALS","author":"Schiffman NI","year":"1996"},{"key":"ref3","series-title":"Handbook of Clinical Neurology: Motor Neuron Disorders and Related Diseases","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0072-9752(07)80004-2","volume-title":"Historical aspects of motor neuron diseases","author":"Eisen AA.","year":"2007"},{"key":"ref4","first-page":"441","article-title":"Electromyographic studies in amyotrophic lateral sclerosis","volume":"32","author":"Lambert EH","year":"1957","journal-title":"Mayo Clinic Proc"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"124","year":"1994","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref6","series-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral dclerosis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.50.3.768","article-title":"Toward earlier diagnosis of amyotrophic lateral sclerosis: Revised criteria","volume":"50","author":"Ross MA","year":"1998","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref8","first-page":"1023","article-title":"New diagnostic criteria of ALS: Awaji criteria","volume":"59","author":"Nodera H","year":"2007","journal-title":"Brain and nerve = Shinkei Kenkyu no Shinpo"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archneur.57.8.1171","article-title":"Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study","volume":"57","author":"Traynor BJ","year":"2000","journal-title":"Arch Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9942","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archneur.57.1.109","article-title":"Amyotrophic lateral sclerosis mimic syndromes: A population-based study","volume":"57","author":"Traynor BJ","year":"2000","journal-title":"Arch Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9942","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1590\/S0004-282X1999000600002","article-title":"Magnetic resonance findings in amyotrophic lateral sclerosis using a spin echo magnetization transfer sequence","volume":"57","author":"Rocha AJ","year":"1999","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1590\/S0004-282X2007000500029","article-title":"Rela\u00e7\u00e3o entre degenera\u00e7\u00e3o do trato c\u00f3rtico-espinhal atrav\u00e9s de resson\u00e2ncia magn\u00e9tica e escala funcional (ALSFRS) em pacientes com esclerose lateral amiotr\u00f3fica","volume":"65","author":"Garcia LN","year":"2007","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref13","series-title":"Esclerose lateral amiotr\u00f3fica: considera\u00e7\u00f5es a respeito dos crit\u00e9rios diagn\u00f3sticos","author":"Chieia MAT","year":"2008"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s004150050358","article-title":"Classification and clinical features of motor neuron diseases and motor neuropathies in adults","volume":"246","author":"Donaghy M","year":"1999","journal-title":"J Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0340-5354","issn-type":"print"},{"key":"ref15","first-page":"84","article-title":"Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial","volume":"5","author":"Leigh PN","year":"2004","journal-title":"ALS"},{"key":"ref16","series-title":"Motor neuron disease (Blue Book): Butterworth-Heinemann","first-page":"167","volume-title":"Epidemiology of amyotrophic lateral sclerosis\/motor neuron disease","author":"Armon C.","year":"2003"},{"key":"ref17","first-page":"S4","article-title":"Current treatment pathways in ALS, a European perspective","volume":"53","author":"Dengler R","year":"1999","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn super oxide dismutase are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen DR","year":"1993","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.410430319","article-title":"Mutations in all five exons of SOD-1 may cause ALS","volume":"43","author":"Shaw CE","year":"1998","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref20","first-page":"7","article-title":"The genetics of ALS\/MND and the role of modifier genes: a clinical perspective","volume":"8","author":"Andersen P","year":"2007","journal-title":"ALS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00415-004-0322-6","article-title":"The future of motor neuron disease","volume":"251","author":"Veldink JH","year":"2004","journal-title":"J Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0340-5354","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","article-title":"A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and ALS","volume":"5","author":"Nihimura AL","year":"2004","journal-title":"Am J Human Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11910-009-0010-0","article-title":"Amyotrophic lateral sclerosis: clinical management and research update","volume":"9","author":"Andrews J","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref24","series-title":"Neuropathology: a reference text of CNS pathology","first-page":"501","volume-title":"Motor neuron disorders","author":"Ellison D","year":"2004"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00019052-200008000-00006","article-title":"Recent advances in amyotrophic lateral sclerosis","volume":"13","author":"Al-Chalabi A","year":"2000","journal-title":"Curr Opin Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/1350-7540","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11910-001-0078-7","article-title":"Progress in the pathogenesis of amyotrophic lateral sclerosis","volume":"1","author":"Shaw CE","year":"2001","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00005072-199905000-00005","article-title":"Neuronal death in amyotrophic lateral sclerosis is apoptosis possible contribution of a programmed cell death mechanism","volume":"58","author":"Martin LJ","year":"1999","journal-title":"J Neuropathol Exp Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3069","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.0305-1846.2001.00332.x","article-title":"Apoptosis in amyotrophic lateral sclerosis: a review of the evidence","volume":"27","author":"Sathasivam S","year":"2001","journal-title":"Neuropathol Appl Neurobiol","ISSN":"https:\/\/id.crossref.org\/issn\/0305-1846","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1471-4159.2006.04408.x","article-title":"Amyotrophic lateral sclerosis: all roads lead to Rome","volume":"101","year":"2007","journal-title":"J Neurochem","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"key":"ref30"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","article-title":"Excitotoxic neuronal death and the pathogenesis of Huntington's disease","volume":"39","author":"S\u00e1nchez AME","year":"2008","journal-title":"Arch Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0188-0128","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: what is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross CA","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1110\/ps.051471205","article-title":"Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences","volume":"14","author":"Tartaglia GG","year":"2005","journal-title":"Protein Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0961-8368","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-4933-3-5","volume":"3","author":"Gupta S","year":"2006","journal-title":"Immunity Ageing"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nri1568","article-title":"The role of BH3-only proteins in the immune system","volume":"5","author":"Strasser A","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref36","series-title":"Neurochemical Aspects of Excitotoxicity","author":"Akhlaq A","year":"2008"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1073\/pnas.88.2.647","article-title":"Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction","volume":"88","author":"Appel SH","year":"1991","journal-title":"Proc Natl Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"ref38","first-page":"63","article-title":"Microglia in amyotrophic lateral sclerosis","volume":"107","author":"Maarten D","year":"2007","journal-title":"Acta Neurol Belg","ISSN":"https:\/\/id.crossref.org\/issn\/0300-9009","issn-type":"print"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajmg.b.30543","article-title":"Genetic susceptibility to environmental toxicants in ALS","volume":"144","author":"Morahan JM","year":"2007","journal-title":"Amer Genet"},{"key":"ref40","first-page":"40","article-title":"New aspects of the cyanobacteria\/BMAA hypothesis and future directions","volume":"9","author":"Bradley W","year":"2008","journal-title":"ALS"},{"key":"ref41","first-page":"545","article-title":"The role of exercise in amyotrophic lateral sclerosis: Physical medicine and rehabilitation","volume":"19","author":"Chen A","year":"2008","journal-title":"Clin North Amer"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1185\/030079904125003296","volume":"20","author":"Piazza O","year":"2004","journal-title":"Curr Med Res Opinion"},{"key":"ref43","first-page":"1","article-title":"All causes mortality in male professional soccer players","author":"Taioli E.","year":"2007","journal-title":"Eur J Pub Health"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2007.10.005","article-title":"Amyotrophic lateral sclerosis and soccer: a different epidemiological approach strengthen the previous findings","volume":"269","author":"Chi\u00f2 A","year":"2008","journal-title":"J Neur Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000277463.87361.8c","article-title":"Lifetime occupation, education, smoking, and risk of ALS","volume":"69","author":"Sutedja NA","year":"2007","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1212\/01.WNL.0000069922.32557.CA","article-title":"Occurrence of amyotrophic lateral sclerosis among Gulf War veterans","volume":"61","author":"Horner RD","year":"2003","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref47","first-page":"1","article-title":"Prognostic factors in ALS: a critical review","volume":"5","author":"Chi\u00f2 A","year":"2008","journal-title":"ALS"},{"key":"ref48","first-page":"37","volume":"6","author":"Paillisse C","year":"2005","journal-title":"ALS"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS: consensus of an International Symposium sponsored by IFCN","volume":"119","author":"de Carvalho M","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.clinph.2008.04.120","article-title":"Distal vs proximal muscle involvement pattern in patients with early-stage amyotrophic lateral sclerosis","volume":"119","author":"Gutierrez J","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"ref51","first-page":"17","article-title":"Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials","volume":"6","author":"Carvalho M","year":"2005","journal-title":"ALS"},{"key":"ref52","first-page":"134","article-title":"Diffusion anisotropy imaging in amyotrophic lateral sclerosis","volume":"8","author":"Oreja-Guevara C","year":"2007","journal-title":"ALS"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1468-1331.2007.01972.x","article-title":"Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype","volume":"14","author":"Zetterberg H","year":"2007","journal-title":"Eur J Neur"},{"key":"ref54","first-page":"10","article-title":"Protein biomarkers for ALS disease progression","volume":"9","author":"Bowser R","year":"2008","journal-title":"ALS"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1007\/s11064-008-9742-5","article-title":"Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS)","volume":"33","author":"Brettschneider J","year":"2008","journal-title":"Neurochem"},{"key":"ref56","series-title":"Ireland, 1995-1997: a population-based study","first-page":"504","volume-title":"Incidence and prevalence of ALS","author":"Traynor BJ","year":"1999"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mus.20555","article-title":"Inappropriate surgeries resulting from misdiagnosis of early amyotrophic lateral sclerosis","volume":"34","author":"Srinivasan J","year":"2006","journal-title":"Muscle Nerve","ISSN":"https:\/\/id.crossref.org\/issn\/0148-639X","issn-type":"print"},{"key":"ref58","author":"Chi\u00f2 A","year":"1994"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1212\/WNL.53.8.26A","article-title":"Diagnostic challenges in ALS","volume":"53","author":"Belsh JM","year":"1999","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jnnp.69.2.178","article-title":"Which neuropsychiatry and behavioral features distinguish frontal and temporal dementia from Alzheimer's disease?","volume":"68","author":"Bozeat S","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref61","first-page":"323","article-title":"The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis","volume":"9","author":"Strong MJ","year":"2008","journal-title":"ALS"},{"key":"ref62","first-page":"1695","article-title":"Transgenic mouse models and human neurodegenerative disorders, Arch","volume":"57","author":"Deng HX","year":"2000","journal-title":"Neurol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0308-4","article-title":"Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences","volume":"115","author":"Kato S","year":"2008","journal-title":"Acta Neuropathol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(07)70244-2","article-title":"Clinical care of patients with amyotrophic lateral sclerosis","volume":"6","author":"Radunovic A","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00127893-199903000-00002","article-title":"Accelerating the diagnosis of amyotrophic lateral sclerosis","volume":"5","author":"Bromberg M.","year":"1999","journal-title":"he Neurologist"},{"key":"ref66","first-page":"S37","article-title":"Honesty and hope: announcement of diagnosis in ALS","volume":"53","author":"Silani V","year":"1999","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/bmj.292.6535.1573","article-title":"Consultation skills of young doctors","volume":"292","author":"Maguire P","year":"1986","journal-title":"BMJ","ISSN":"https:\/\/id.crossref.org\/issn\/0959-8138","issn-type":"print"},{"key":"ref68","series-title":"Handbook of Clinical Neurology, vol82 (3rd series): Motor neuron diseases and related disorders","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0072-9752(07)80022-4","volume-title":"Therapies in amyotrophic lateral sclerosis: options for the near and far future","author":"Lemmens R","year":"2007"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000223353.34006.54","article-title":"Neuroprotective agents for clinical trials in ALS: a systematic assessment","volume":"67","author":"Traynor BJ","year":"2006","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pmr.2008.02.002","article-title":"Designing clinical trials in amyotrophic lateral sclerosis","volume":"19","author":"Shefner JM","year":"2008","journal-title":"Phys Med Rehab Clin North America"},{"key":"ref71","first-page":"270","article-title":"Outcome measures for early phase clinical trials","volume":"8","author":"Gordon PH","year":"2007","journal-title":"ALS"},{"key":"ref72","first-page":"25","article-title":"Clinical trial of celecoxib in subjects with amyotrophic lateral sclerosis","volume":"5","author":"Cudkowicz ME","year":"2004","journal-title":"ALS"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10374","article-title":"Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS","volume":"52","author":"Drachman DB","year":"2002","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi P","year":"1999","journal-title":"Nat Med","ISSN":"https:\/\/id.crossref.org\/issn\/1078-8956","issn-type":"print"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.10554","article-title":"A randomized sequential trial of creatine in amyotrophic lateral sclerosis","volume":"53","author":"Groeneveld GJ","year":"2003","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney ME","year":"1996","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1212\/WNL.56.7.843","article-title":"Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis","volume":"56","author":"Miller RG","year":"2001","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1097\/00001756-200008030-00029","article-title":"N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis","volume":"11","author":"Andreassen OA","year":"2000","journal-title":"Neuroreport","ISSN":"https:\/\/id.crossref.org\/issn\/0959-4965","issn-type":"print"},{"key":"ref79","first-page":"281","article-title":"Therapeutic trial with N-acetylcysteine in amyotrophic lateral sclerosis","volume":"209","author":"Kuther G","year":"1987","journal-title":"Adv Exp Med Biol","ISSN":"https:\/\/id.crossref.org\/issn\/0065-2598","issn-type":"print"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis","volume":"330","author":"Bensimon G","year":"1994","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"For the amyotrophic lateral sclerosis \/ Riluzole Study group II: Dose-ranging study for riluzole in amyotrophic lateral sclerosis","volume":"347","author":"Lacomblez L","year":"1996","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1212\/WNL.47.6_Suppl_4.242S","article-title":"A confirmatory dose-ranging study of riluzole in ALS","volume":"47","author":"Lacomblez L","year":"1996","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref83","first-page":"68","article-title":"Disease-modifying drug therapies","volume":"5","author":"Brooks BR","year":"2004","journal-title":"ALS and other motor neuron disorders"},{"key":"ref84","first-page":"195","volume":"9","author":"Richard OW","year":"2008","journal-title":"ALS"},{"key":"ref85","series-title":"Amyotrophic lateral sclerosis: Contemporary neurology series","author":"Mitsumoto H","year":"1998","edition":"1"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/01.wnl.0000327290.13342.0a","article-title":"A randomized controlled trial of resistance exercise in individuals with ALS","volume":"71","author":"Bello-Haas VD","year":"2008","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham KJ","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref88","series-title":"PROCLIM - Programa de Atualiza\u00e7\u00e3o em Cl\u00ednica M\u00e9dica","first-page":"105","volume-title":"Doen\u00e7a do neur\u00f4nio motor","author":"Chiappetta ALML","year":"2005"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson C","year":"2009","journal-title":"Muscle Nerve","ISSN":"https:\/\/id.crossref.org\/issn\/0148-639X","issn-type":"print"},{"key":"ref90","first-page":"70","article-title":"Suplementa\u00e7\u00e3o nutricional em pacientes com doen\u00e7a do neur\u00f4nio motor\/esclerose lateral amiotr\u00f3fica","volume":"19","author":"Stanich P","year":"2004","journal-title":"Rev Bras Nut Cl\u00edn"},{"key":"ref91","first-page":"79","article-title":"Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis: role of BiPAP ventilation","volume":"8","author":"Hartmann S","year":"2007","journal-title":"ALS"},{"key":"ref92","first-page":"59","article-title":"Causes of death in a post-mortem series of ALS patients","volume":"9","author":"Corcia P","year":"2008","journal-title":"ALS"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.10487","article-title":"Pulmonary complications of chronic neuromuscular disease and their management","volume":"29","author":"Perrin C","year":"2004","journal-title":"Muscle Nerve","ISSN":"https:\/\/id.crossref.org\/issn\/0148-639X","issn-type":"print"},{"key":"ref94","first-page":"85","article-title":"Artificial ventilatory management in long-term hospitalized patients with amyotrophic lateral sclerosis at a Japanese Hospital for chronic neuromuscular disoders","volume":"8","author":"Takada H","year":"2007","journal-title":"ALS"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis","volume":"5","author":"Bourke SC","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref96","first-page":"54","article-title":"Results of prospective pilot and multi-center pivotal trials of diaphragm pacing in amyotrophic lateral sclerosis: maintaining diaphragm function and improving survival","volume":"9","author":"Onders R","year":"2008","journal-title":"ALS"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1212\/WNL.52.7.1311","article-title":"Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology","volume":"52","author":"Miller RG","year":"1999","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpainsymman.2005.04.010","article-title":"When patients lack capacity: the role that patients with terminal diagnoses would choose for their physicians and loved ones in making medical decisions","volume":"30","author":"Nolan MT","year":"2005","journal-title":"J Pain Symptom Management"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.55.10.1581","article-title":"Impact of spirituality and religiousness on outcomes in patients with ALS","volume":"55","author":"Murphy PL","year":"2000","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref100","series-title":"Amyotrophic lateral sclerosis: a comprehensive guide to management","first-page":"271","volume-title":"Meditation and ALS","author":"Borasio GD.","year":"2001"},{"key":"ref101","series-title":"Handbook of Clinical Neurology: Vol. 82 (3rd series) Motor neuron disorders and related diseases","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0072-9752(07)80023-6","volume-title":"Syntomatic therapy and palliative aspects of clinical care","author":"Gordon PH","year":"2007"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.298.2.207","article-title":"Palliative care for patients with amyotrophic lateral sclerosis: prepare for the worst and hope for the best","volume":"298","author":"Mitsumoto H","year":"2007","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/07434610600650276","article-title":"Purposes of AAC device use for persons with ALS as reported by caregivers","volume":"20","author":"Fried-Oken M","year":"2006","journal-title":"Augmentative Alternative Communication"},{"key":"ref104","series-title":"What is CAM?: NCCAM Publication; No. D347","year":"2007"},{"key":"ref105","first-page":"2520","article-title":"Quality of life of patients with amyotrophic lateral sclerosis","volume":"126","author":"Leirvik A","year":"2006","journal-title":"Tidsskr Nor Laegeforen","ISSN":"https:\/\/id.crossref.org\/issn\/0029-2001","issn-type":"print"},{"key":"ref106","first-page":"131","article-title":"Therapy development for ALS: lessons learned and path forward","volume":"9","author":"Lanka V","year":"2008","journal-title":"ALS"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon PH","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(04)16634-8","article-title":"Stem-cell therapy for amyotrophic lateral sclerosis","volume":"364","author":"Silani V","year":"2004","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref109","first-page":"908","volume":"15","author":"Mazzini L.","year":"2002","journal-title":"J Neurosci Res","ISSN":"https:\/\/id.crossref.org\/issn\/0360-4012","issn-type":"print"},{"key":"ref110","first-page":"158","article-title":"Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans","volume":"4","author":"Mazzini L","year":"2003","journal-title":"ALS"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2007.05.016","article-title":"Stem cell treatment in amyotrophic lateral sclerosis","volume":"265","author":"Mazzini L","year":"2008","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki M","year":"2008","journal-title":"Molec Therapy"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tins.2008.01.006","article-title":"Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis","volume":"31","author":"Suzuki M","year":"2008","journal-title":"Trends Neurosci","ISSN":"https:\/\/id.crossref.org\/issn\/0166-2236","issn-type":"print"},{"key":"ref114","first-page":"32","article-title":"Unproven cell-based treatments for ALS\/MND: lessons from Beijing","volume":"8","year":"2007","journal-title":"ALS"},{"key":"ref115","first-page":"314","volume":"8","author":"Chew S","year":"2007","journal-title":"ALS"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4161\/auto.5923","article-title":"Autophagy and ALS: the multiple roles of lithium","volume":"4","author":"Fornai F","year":"2008","journal-title":"Autophagy"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of ALS","volume":"105","author":"Fornai F","year":"2008","journal-title":"Proc Natl Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"ref118","first-page":"59","article-title":"A patient-led trial of lithium in ALS using the internet","volume":"9","author":"Wicks P","year":"2008","journal-title":"ALS"},{"key":"ref119","article-title":"Lithium carbonate treatment does not improve the disease progression in two different strains of SOD1 mutant mice","author":"Pizzasegola C","year":"2008","journal-title":"ALS"},{"key":"ref120","first-page":"122","article-title":"Lithium therapy in ALS","volume":"9","author":"Meininger V","year":"2008","journal-title":"ALS"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0278-5846(03)00025-3","article-title":"Prospects for antiapoptotic drug therapy of neurodegenerative diseases","volume":"27","author":"Waldmeier PC","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0278-5846","issn-type":"print"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mus.21059","article-title":"Arimoclomol at dosages up to 300 mg\/day is well tolerated and safe in amyotrophic lateral sclerosis","volume":"38","author":"Cudkowicz ME","year":"2008","journal-title":"Muscle Nerve","ISSN":"https:\/\/id.crossref.org\/issn\/0148-639X","issn-type":"print"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1517\/14656566.9.11.1845","article-title":"A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies","volume":"9","author":"Yamamoto M","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1523\/JNEUROSCI.1092-08.2008","article-title":"Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its Ligand VEGF-B in motor neuron degeneration","volume":"28","author":"Koen P","year":"2008","journal-title":"J Neurosci","ISSN":"https:\/\/id.crossref.org\/issn\/0270-6474","issn-type":"print"},{"key":"ref125","first-page":"150","article-title":"Immunization strategy for treating amyotrophic lateral sclerosis that targets misfolded SOD1","volume":"1","author":"Liu HNS","year":"2007","journal-title":"ALS"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar BK","year":"2003","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno CS","year":"2003","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2990.2007.00883.x","article-title":"Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease","volume":"33","author":"Christou YA","year":"2007","journal-title":"Neuropathol Appl Neurobiol","ISSN":"https:\/\/id.crossref.org\/issn\/0305-1846","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v67n3a\/v67n3aa40.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T10:18:11Z","timestamp":1495793891000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2009000400040&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":128,"journal-issue":{"issue":"3a","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0004-282X2009000400040"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2009000400040","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}